Abdelali (Ali) Majdi, MD
@alitimumab.bsky.social
#MedicalAffairs | #PatientCentricity #PrecisionOncology 🧬 #RareDiseases #CardioMed 🫀 #Evidence #Innovation #Care #Diversity #Inclusion #MedSky #LCSM 🫁 #PCSM 👨🏻
Reposted by Abdelali (Ali) Majdi, MD
The FDA approved larotrectinib for adult and pediatric patients with NTRK gene fusion-positive cancer tumors. What does this mean? LCRF's Chief Scientific Officer, Dr. Antoinette Wozniak, explains: LCRF.org/sms250424 #LungCancer #ScienceMadeSimple
Science Made Simple: drug approval for NTRK - Lung Cancer Research Foundation
The good news The Food and Drug Administration (FDA) approved larotrectinib (Vitrakvi) for adult and pediatric patients with NTRK gene fusion-positive solid tumors. Why it’s important Neurotrophic…
LCRF.org
April 24, 2025 at 7:00 PM
The FDA approved larotrectinib for adult and pediatric patients with NTRK gene fusion-positive cancer tumors. What does this mean? LCRF's Chief Scientific Officer, Dr. Antoinette Wozniak, explains: LCRF.org/sms250424 #LungCancer #ScienceMadeSimple
Reposted by Abdelali (Ali) Majdi, MD
Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer | JCO Precision Oncology ascopubs.org/doi/10.1200/...
Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer | JCO Precision Oncology
PURPOSENeurotrophic tyrosine receptor kinase gene fusions are oncogenic drivers of various
solid tumors. Larotrectinib is a highly selective tropomyosin receptor kinase (TRK)
inhibitor approved for pa...
ascopubs.org
April 25, 2025 at 12:26 PM
Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer | JCO Precision Oncology ascopubs.org/doi/10.1200/...
💥 Big impact already! The Tin Soldiers - Unjani Clinic MSK Screening Pilot Project is making waves, increasing awareness and skills in pediatric musculoskeletal care.
🎥 Watch the video ! 👀👇
👉 youtu.be/avqGKzl5S8A?...
🎥 Watch the video ! 👀👇
👉 youtu.be/avqGKzl5S8A?...
An Army of Eyes
YouTube video by Tin Soldiers
youtu.be
April 3, 2025 at 4:11 PM
💥 Big impact already! The Tin Soldiers - Unjani Clinic MSK Screening Pilot Project is making waves, increasing awareness and skills in pediatric musculoskeletal care.
🎥 Watch the video ! 👀👇
👉 youtu.be/avqGKzl5S8A?...
🎥 Watch the video ! 👀👇
👉 youtu.be/avqGKzl5S8A?...
Two decades ago, Roger Stupp's pivotal @NEJM paper set a new standard for glioblastoma 🧠 with the combination of radiotherapy and temozolomide. Yet, progress has been incremental. GBM remains a formidable challenge, urging us to innovate further.
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma | NEJM
Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal.
The current standard of care for newly diagnosed glioblastoma is surgical resection
to the extent feasible, fo...
www.nejm.org
March 16, 2025 at 8:41 AM
Two decades ago, Roger Stupp's pivotal @NEJM paper set a new standard for glioblastoma 🧠 with the combination of radiotherapy and temozolomide. Yet, progress has been incremental. GBM remains a formidable challenge, urging us to innovate further.
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
Reposted by Abdelali (Ali) Majdi, MD
Huge congratulations to Doug Hanahan for the 2025 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research 🎉
A well-deserved honor for such an incredible scientist, inspiring leader & generous mentor!
@theaacr.bsky.social
#cancer #research 🧪
brnw.ch/21wRfD0
A well-deserved honor for such an incredible scientist, inspiring leader & generous mentor!
@theaacr.bsky.social
#cancer #research 🧪
brnw.ch/21wRfD0
March 11, 2025 at 7:18 PM
Huge congratulations to Doug Hanahan for the 2025 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research 🎉
A well-deserved honor for such an incredible scientist, inspiring leader & generous mentor!
@theaacr.bsky.social
#cancer #research 🧪
brnw.ch/21wRfD0
A well-deserved honor for such an incredible scientist, inspiring leader & generous mentor!
@theaacr.bsky.social
#cancer #research 🧪
brnw.ch/21wRfD0
Reposted by Abdelali (Ali) Majdi, MD
3 points of progress vs pancreatic cancer!
1. Neoantigen vaccines
www.nature.com/articles/s41...
2. KRAS drugs
www.wsj.com/health/healt...
3. Early diagnosis www.science.org/doi/10.1126/...
1. Neoantigen vaccines
www.nature.com/articles/s41...
2. KRAS drugs
www.wsj.com/health/healt...
3. Early diagnosis www.science.org/doi/10.1126/...
March 1, 2025 at 3:26 PM
3 points of progress vs pancreatic cancer!
1. Neoantigen vaccines
www.nature.com/articles/s41...
2. KRAS drugs
www.wsj.com/health/healt...
3. Early diagnosis www.science.org/doi/10.1126/...
1. Neoantigen vaccines
www.nature.com/articles/s41...
2. KRAS drugs
www.wsj.com/health/healt...
3. Early diagnosis www.science.org/doi/10.1126/...
✨ Today is #RareDiseaseDay, a global moment to unite in support of those living with rare diseases 🌍
Better awareness, early detection, and timely diagnosis are crucial to improving patient outcomes
Better awareness, early detection, and timely diagnosis are crucial to improving patient outcomes
February 28, 2025 at 8:15 PM
✨ Today is #RareDiseaseDay, a global moment to unite in support of those living with rare diseases 🌍
Better awareness, early detection, and timely diagnosis are crucial to improving patient outcomes
Better awareness, early detection, and timely diagnosis are crucial to improving patient outcomes
Reposted by Abdelali (Ali) Majdi, MD
Timothy A. Yap, MBBS, PhD, has been appointed editor-in-chief of the AACR journal Clinical Cancer Research. Dr. Yap is co-director for the AACR/ASCO Methods in Clinical Cancer Research Workshop and a past cochair of the AACR Annual Meeting Clinical Trials Committee. www.aacr.org/about-the-aa...
February 24, 2025 at 9:58 PM
Timothy A. Yap, MBBS, PhD, has been appointed editor-in-chief of the AACR journal Clinical Cancer Research. Dr. Yap is co-director for the AACR/ASCO Methods in Clinical Cancer Research Workshop and a past cochair of the AACR Annual Meeting Clinical Trials Committee. www.aacr.org/about-the-aa...
Just one small positive thought in the morning can change your whole day.
January 4, 2025 at 11:07 AM
Just one small positive thought in the morning can change your whole day.
Reposted by Abdelali (Ali) Majdi, MD
Raise your awareness before you raise your glass. Discover how alcohol consumption could impact your cancer risk and the steps you can take to prioritize your health.
What You Should Know About Alcohol Consumption and Cancer Risk
Discover the connection between alcohol consumption and elevated cancer risk.
bit.ly
January 3, 2025 at 10:30 PM
Raise your awareness before you raise your glass. Discover how alcohol consumption could impact your cancer risk and the steps you can take to prioritize your health.
RIP my friend 🙏
Maya 🤍
September 2007 - December 2024
Maya 🤍
September 2007 - December 2024
December 11, 2024 at 2:53 PM
RIP my friend 🙏
Maya 🤍
September 2007 - December 2024
Maya 🤍
September 2007 - December 2024
Reposted by Abdelali (Ali) Majdi, MD
Hello, #MedSky community! We’re excited to begin our Bluesky journey.
Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
December 6, 2024 at 8:24 PM
Hello, #MedSky community! We’re excited to begin our Bluesky journey.
Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
www.nature.com/articles/d41...
Science vs. Politics.
“It’s a constant tension between the scientifically illiterate and the politically clueless,” Paul Dufour, University of Ottawa, Canada
Science vs. Politics.
“It’s a constant tension between the scientifically illiterate and the politically clueless,” Paul Dufour, University of Ottawa, Canada
Science could solve some of the world’s biggest problems. Why aren’t governments using it?
A Nature global survey finds that most specialists are unhappy with systems to provide science advice to policymakers.
www.nature.com
December 6, 2024 at 10:17 PM
www.nature.com/articles/d41...
Science vs. Politics.
“It’s a constant tension between the scientifically illiterate and the politically clueless,” Paul Dufour, University of Ottawa, Canada
Science vs. Politics.
“It’s a constant tension between the scientifically illiterate and the politically clueless,” Paul Dufour, University of Ottawa, Canada
Reposted by Abdelali (Ali) Majdi, MD
Join Drs. Gillessen, Omlin, Castro, Zilli, Tombel & Turco as they discuss Advanced Prostate Cancer Consensus Conference 2024, presentation at #PROSCA24
#ProstateCancer
https://buff.ly/3B5902t
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@achoud72.bsky.social
@pgrivasmdphd.bsky.social
#ProstateCancer
https://buff.ly/3B5902t
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@achoud72.bsky.social
@pgrivasmdphd.bsky.social
Highlights from APCCC 2024 in Prostate Cancer Final day of #PROSCA24
The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in prostate cancer management while underscoring areas where h...
buff.ly
November 30, 2024 at 2:53 PM
Join Drs. Gillessen, Omlin, Castro, Zilli, Tombel & Turco as they discuss Advanced Prostate Cancer Consensus Conference 2024, presentation at #PROSCA24
#ProstateCancer
https://buff.ly/3B5902t
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@achoud72.bsky.social
@pgrivasmdphd.bsky.social
#ProstateCancer
https://buff.ly/3B5902t
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@achoud72.bsky.social
@pgrivasmdphd.bsky.social
November 29, 2024 at 10:37 AM
List of Social Media Oncology Hashtags (table from ASCO)
November 24, 2024 at 9:28 PM
List of Social Media Oncology Hashtags (table from ASCO)
Enhancing Patient Navigation with Technology to Improve Equity in Cancer Care
A Report from the President's Cancer Panel
https://buff.ly/3V85qLE
A Report from the President's Cancer Panel
https://buff.ly/3V85qLE
November 24, 2024 at 1:44 PM
Enhancing Patient Navigation with Technology to Improve Equity in Cancer Care
A Report from the President's Cancer Panel
https://buff.ly/3V85qLE
A Report from the President's Cancer Panel
https://buff.ly/3V85qLE
Reposted by Abdelali (Ali) Majdi, MD
I made a #LCSM list, small but growing! Not sure how to make it public? bsky.app/profile/did:...
@jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social
@jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social
November 10, 2024 at 7:32 PM
I made a #LCSM list, small but growing! Not sure how to make it public? bsky.app/profile/did:...
@jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social
@jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social
´A place of joy’: why scientists are joining the rush to Bluesky 🦋
www.nature.com/articles/d41...
www.nature.com/articles/d41...
November 22, 2024 at 7:46 PM
´A place of joy’: why scientists are joining the rush to Bluesky 🦋
www.nature.com/articles/d41...
www.nature.com/articles/d41...
Reposted by Abdelali (Ali) Majdi, MD
Sharing a fledgling #LCSM starter pack for those joining Bluesky 🦋
#Medsky #Oncsky @oncoalert.bsky.social
go.bsky.app/MjDxbG2
#Medsky #Oncsky @oncoalert.bsky.social
go.bsky.app/MjDxbG2
November 19, 2024 at 2:00 PM
Sharing a fledgling #LCSM starter pack for those joining Bluesky 🦋
#Medsky #Oncsky @oncoalert.bsky.social
go.bsky.app/MjDxbG2
#Medsky #Oncsky @oncoalert.bsky.social
go.bsky.app/MjDxbG2
Reposted by Abdelali (Ali) Majdi, MD
It was an honor to co-author this article
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
Lung cancer—a one-way ticket
The physician’s duty is not to stave off death or return patients to their old lives, but to take into our arms a patient and family whose lives have disin
bit.ly
November 21, 2024 at 3:45 AM
It was an honor to co-author this article
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
Another day in Paris ❄️
#Grogu at Les Rencontres Phases Précoces en Cancérologie #EarlyPhaseClinicalResearch #Oncology
https://buff.ly/3V41Imh
#Grogu at Les Rencontres Phases Précoces en Cancérologie #EarlyPhaseClinicalResearch #Oncology
https://buff.ly/3V41Imh
November 21, 2024 at 8:15 AM
Another day in Paris ❄️
#Grogu at Les Rencontres Phases Précoces en Cancérologie #EarlyPhaseClinicalResearch #Oncology
https://buff.ly/3V41Imh
#Grogu at Les Rencontres Phases Précoces en Cancérologie #EarlyPhaseClinicalResearch #Oncology
https://buff.ly/3V41Imh